Clinical Trial Update: Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating semaglutide alone and in combination with cilofexor and firsocostat for cirrhosis due to nonalcoholic steatohepatitis. Results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Cilofexor (cilofexor)
• Firsocostat (firsocostat)
• semaglutide (semaglutide)

Snippet

Sponsor: Gilead Sciences | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-11-26